MDMA proves a promising alcoholism treatment in world-first trial

A new study published in the Journal of Psychopharmacology is reporting on a landmark clinical trial exploring the potential for MDMA-assisted psychotherapy in treating subjects with alcohol use disorder. The small open-label trial is the first to test… Continue reading MDMA proves a promising alcoholism treatment in world-first trial

Landmark study finds link between playing video games and well-being

A first-of-its-kind study from Oxford University has investigated the relationship between well-being and time spent playing video games using novel industry data from two popular video games. The surprising findings revealed a small correlation betwee… Continue reading Landmark study finds link between playing video games and well-being

MDMA-assisted couples therapy investigated in landmark pilot trial

In the late 1970s and early 1980s MDMA was often utilized to help facilitate positive results in couples counseling. A few dozen pioneering psychotherapists in the United States explored the drug’s therapeutic uses until the US government declared MDMA… Continue reading MDMA-assisted couples therapy investigated in landmark pilot trial

Cannabis may reduce acute OCD symptoms, but long-term effects unclear

Research from Washington State University (WSU), and published in The Journal of Affective Disorders, is reporting some people find their symptoms of obsessive-compulsive disorder (OCD) dramatically drop after smoking cannabis. The study suggests the i… Continue reading Cannabis may reduce acute OCD symptoms, but long-term effects unclear

Novel blood test predicts psychotic disorders years before they emerge

An international team of researchers has used machine learning to produce a novel blood test that can predict a young person’s risk of developing a psychotic disorder, such as schizophrenia, years before the condition develops.Continue ReadingCategory:… Continue reading Novel blood test predicts psychotic disorders years before they emerge

Landmark clinical trial exploring LSD-MDMA combo to begin late 2020

Psychedelic pharmaceutical company MindMed is set to conduct a novel Phase 1 clinical trial exploring the subjective effects of combining LSD with MDMA. The primary goal of the prospective study is to investigate whether MDMA, a drug known to induce fe… Continue reading Landmark clinical trial exploring LSD-MDMA combo to begin late 2020

Low suicide rates linked to microdoses of lithium in drinking water

A new systematic review of more than a dozen studies from around the world has confirmed an association between geographical areas with naturally high levels of lithium in the water supply and low rates of suicide. The researchers suggest trials should… Continue reading Low suicide rates linked to microdoses of lithium in drinking water

Remote therapy for depression as effective as meeting in person, metastudy finds

A systemic review of 17 randomized control trials has concluded cognitive behavioral therapy does not need to be conducted in person to be effective. The study found, for depression, the therapy was as effective when administered remotely using video c… Continue reading Remote therapy for depression as effective as meeting in person, metastudy finds

Horror film fans are dealing with COVID-19 better than most, study finds

A new study, conducted over the past few months in the shadow of the COVID-19 pandemic, has found fans of apocalyptic and horror media are reporting less distress and greater resilience during this real pandemic compared to those who don’t consume thos… Continue reading Horror film fans are dealing with COVID-19 better than most, study finds

Controversial pedophile study finds drug may reduce risk of child sexual abuse

Four years after it was first announced, the results of a controversial clinical trial have finally been published in the journal JAMA Psychiatry. The study found a testosterone-reducing drug, originally developed as a prostate cancer treatment, lowere… Continue reading Controversial pedophile study finds drug may reduce risk of child sexual abuse